MULTUS Biotechnology Limited announced that it has raised $7 million in round of funding led by Mandi Ventures on January 16, 2023. The transaction included the participation from Big Idea Ventures, SynBioVen, and Asahi Kasei Corp, existing investor SOSV Investments LLC.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,068 JPY | +2.30% |
|
+1.62% | +2.79% |
13/06 | Asahi Kasei Launches Membrane System to Produce Water for Injection | CI |
06/06 | Asahi Kasei Micro Devices Launches CQ36 Series Integrated Circuit with Built-In DS Modulator | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.79% | 9.13B | |
+15.21% | 84.28B | |
-9.10% | 42.56B | |
+6.86% | 34.37B | |
+16.94% | 19.33B | |
+11.53% | 11.78B | |
-12.59% | 9.41B | |
-3.49% | 8.49B | |
+6.47% | 8.17B | |
-13.95% | 5.63B |
- Stock Market
- Equities
- 3407 Stock
- News Asahi Kasei Corporation
- MULTUS Biotechnology Limited announced that it has received $7 million in funding from SOSV Investments LLC, Mandi Ventures, Big Idea Ventures, LLC, SynBioVen Limited, Asahi Kasei Corporation